Treat-to-Target Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Comparator) in Basal Therapy for Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2012
At a glance
- Drugs Insulin detemir; Insulin neutral protamine lispro
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms COMPLETE T2D
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 13 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2007-002150-39).
- 10 Nov 2009 Actual patient number changed from 377 to 442 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History